Shigeki Sekine

20PUBLICATIONS
63CO-AUTHORS
Oncology and carcinogenesis not elsewhere classifiedPredictive and prognostic markersSolid tumoursCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Sep 05, 2026
PD-L1 expression and survival in unresectable/recurrent gastric cancer treated by 1st-line treatment without immune checkpoint inhibitors: JCOG1013A1.

|Jun 12, 2026
Recurrent COPA mutation drives R-spondin-independent Wnt activation in intestinal tumors.

|Jun 02, 2026
Traditional serrated adenoma of the colorectum: Evolving concepts in histological classification and terminology.

|May 03, 2025
Human Papillomavirus-Related Adenosquamous Carcinoma of the Anorectum With Pagetoid Spread.

Kenta Seki, Taiki Hashimoto, Hiroshi Nagata

|Mar 29, 2025
Quantifying CD73 expression after chemotherapy or chemoradiotherapy in esophageal squamous cell carcinoma.

Zachary A Cooper, Ying Wang, Philip L Martin

|Oct 11, 2023
Phase II Trial of Nivolumab in Metastatic Rare Cancer with dMMR or MSI-H and Relation with Immune Phenotypic Analysis (the ROCK Trial).

Hitomi S Okuma, Keisuke Watanabe, Kenji Tsuchihashi

Pageof 4

Frequent Collaborators

7 joint publications

Taiki Hashimoto

4 joint publications

Yasushi Yatabe

3 joint publications

Kengo Nagashima

2 joint publications

Kouya Shiraishi